Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population

BACKGROUND: Evidence regarding the efficacy or effectiveness of the disease-modifying drugs (DMDs) in the older multiple sclerosis (MS) population is scarce. This has contributed to a lack of evidence-based treatment recommendations for the ageing MS population in practice guidelines. We examined th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Huah Shin, Graf, Jonas, Zhu, Feng, Kingwell, Elaine, Aktas, Orhan, Albrecht, Philipp, Hartung, Hans-Peter, Meuth, Sven G., Evans, Charity, Fisk, John D., Marrie, Ruth Ann, Zhao, Yinshan, Tremlett, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792855/
https://www.ncbi.nlm.nih.gov/pubmed/35095869
http://dx.doi.org/10.3389/fimmu.2021.794075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792855/
https://www.ncbi.nlm.nih.gov/pubmed/35095869
http://dx.doi.org/10.3389/fimmu.2021.794075

Ejemplares similares